186 studies on Mgf curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
| Manufacturer | Batches | Avg purity | |
|---|---|---|---|
| Simple Peptide | 3 | 99.64% | View COA → |
| Alpha & Omega | 3 | 99.64% | View COA → |
Recent certificates: #15169 (99.491%) · #46295 (99.873%) · #24549 (99.493%) · #45764 (99.614%) · #60659 (99.25%) · #62569 (99.25%)
Manufacturers with published third-party certificates of analysis for Mgf. Open a vendor to see every batch we've verified.
**Understanding the re-treatment protocols for Serostim® in HARS is crucial for optimizing long-term management strategies.** While specific efficacy data are absent from this abstract, the detailed description of saf…
MetNET1 prospective trial will evaluate Everolimus, Octreotide LAR, and Metformin combination for advanced pancreatic well-differentiated neuroendocrine tumors (pWDNETs).
Understanding how different insulin analogs modulate the `GH-IGF-IGFBP` axis is crucial for optimizing long-term **Type 1 Diabetes** management and minimizing potential risks. If certain insulins significantly alter `…
A proof-of-principle trial investigates **SOM230**'s ability to reduce cell proliferation and increase apoptosis in the mammary glands of high-risk women, mirroring rat study results.
First-in-human Phase I trial aims to establish BI 836845's maximum tolerated dose (MTD) and safety profile in advanced solid tumor patients.
This cross-sectional study investigates the relationship between serum **IGF-1** levels, **BMI**, and **Acne Vulgaris** in a clinical population.
A European retrospective observational study collected Norditropin® efficacy and safety data in children with Prader-Willi Syndrome to support regulatory approval.
Pegvisomant is being investigated in a 36-week clinical trial to reduce `IGF-1` levels and mitigate growth hormone excess effects in **McCune-Albright Syndrome** patients.
Understanding the comparative safety of different **somatropin** formulations is crucial for optimizing treatment protocols for **children with growth hormone deficiency**. If one formulation demonstrates a superior s…
Understanding the long-term impact of early life interventions like nurse home-visiting programs is crucial for public health strategies. If this study reveals a significant reduction in chronic disease risk among off…
This study provides compelling evidence that **IGF-1 is a key mediator in the link between obesity and liver cancer**, suggesting that maintaining healthy IGF-1 levels could be a strategy to mitigate risk. For individ…
This extensive prospective analysis provides unprecedented clarity on the complex, non-linear relationship between circulating **IGF-1** levels and a wide array of **digestive diseases**. **The key takeaway for clinic…
If successful, this trial could establish **mecasermin** as a critical adjunctive therapy for **heart attack patients**, potentially altering the trajectory of **post-infarction heart failure**. Currently, interventio…
While specific results are not available, this study's design highlights a critical area of research for **chronic patellar tendinopathy**. If `IGF-I` proves effective in stimulating collagen synthesis and improving t…
Understanding the long-term effects of post-discharge nutrition is crucial for **optimizing care protocols for preterm infants**. The findings from this study could provide evidence-based guidance for clinicians and p…
This research significantly strengthens the evidence for **IGF-I** as a contributing factor to **Multiple Myeloma (MM)** susceptibility, moving beyond inconsistent prior findings. The combined power of large-scale obs…
Understanding how **luteinizing hormone (LH)** sensitivity to **energy availability** changes with **gynecological age** in adolescence holds significant implications for **female reproductive health** and **pubertal …
**Establishing safe dosing for novel agents in pediatric oncology is a critical first step towards improving treatment outcomes.** This Phase 1/1B study is foundational, aiming to identify safe and tolerable combinati…
If successful, this study could introduce a **new first-line treatment option for metastatic pancreatic cancer**, a disease with notoriously poor prognosis. The combination of novel agents **AMG 655** or **AMG 479** w…
A clinical trial investigated adding **CP-751,871** to erlotinib therapy to improve overall survival in patients with advanced, refractory non-adenocarcinoma NSCLC.
This research provides crucial insights for clinicians and patients considering FET protocols, particularly regarding potential long-term pregnancy outcomes. **The choice of FET protocol may directly influence early p…
The ATYR1940 study extension seeks to characterize the safety, tolerability, pharmacokinetics, and activity of the compound in adult muscular dystrophy patients.
A non-randomized study assessed repeated modified fasting in 36 healthy volunteers to prevent weight gain over the winter holiday period; no results were provided.
If successful, this research could establish a **whole food plant-based diet** as a significant non-pharmacological intervention for men with **prostate cancer** experiencing rising **PSA**. This could offer a complem…
Understanding the pharmacokinetic profile of **Somatropin** in patients with **End Stage Renal Disease (ESRD)** on **haemodialysis** is critical for safe and effective treatment. **This research is foundational for es…
If this trial demonstrates a significant difference in outcomes based on protein timing, it could **optimize dietary strategies for older adults** aiming to combat sarcopenia and maintain cognitive function. A clear r…
If successful, this research could significantly impact **breast cancer** treatment protocols by offering a simple, non-pharmacological strategy to improve chemotherapy tolerability and potentially efficacy. **Integra…
**AVE1642** anti-`IGF-1R` antibody study aims to establish optimal dose and safety in advanced **multiple myeloma** patients.
In acromegaly, IGF-I is proposed as an intensity marker, not a cause of insulin resistance; GH is hypothesized to induce IR via free fatty acids.
A new trial aims to establish the bioequivalence of two somatropin brands, **Norditropin®** and **Genotropin®**, in healthy adults to ensure comparable therapeutic effects.
This study provides compelling evidence that **MK-0677** can effectively raise **IGF-1** levels in hemodialysis patients, offering a potential oral alternative to injectable growth hormone for combating **protein-ener…
This prospective study is critical for understanding the long-term impact of different growth hormone regimens on the metabolic and growth profiles of children with **GHD**. By comparing daily **rhGH** and weekly **LA…
**Incorporating resistance training into care plans for elderly sarcopenic patients could offer a dual benefit, addressing both muscle health and sleep quality.** Improved sleep can enhance recovery, mood, cognitive f…
Two 12-week HIIT cycles will be studied for impact on dopamine levels, motor function, and neurotrophic factors in Parkinson's disease patients.
Identifying a safe and tolerable dosing regimen for novel combination therapies is a critical first step in cancer drug development. **This study lays the groundwork for potentially effective new treatments for advanc…
While no results are presented, this pilot study's design is relevant for exploring accessible intermittent fasting protocols. If positive findings emerge, **a simple 'Monday is Fasting Day' approach could offer a pra…
**Noonan Syndrome** is a genetic disorder often associated with significant short stature, requiring growth hormone therapy. This trial's findings, once available, could provide critical long-term efficacy and safety …
This research is crucial for advancing personalized medicine in **orthopedic trauma**, particularly for **clavicle fracture management**. By developing a robust risk score, clinicians can move beyond a one-size-fits-a…
This trial represents a crucial step towards a more patient-friendly treatment for **SGA short stature**. **Pegylated Somatropin**, administered weekly, could significantly enhance treatment adherence and reduce the b…
A successful once-weekly **Somapacitan** regimen could revolutionize pediatric growth hormone therapy, significantly reducing the burden of daily injections for children and their families. **Improved adherence to tre…
This study provides compelling evidence that **Quercetin** can directly modulate the `IGF1` signaling axis in **gastric cancer**, offering a promising natural compound for therapeutic intervention. **Targeting `IGF1` …
Debio 4126's pharmacokinetics, pharmacodynamics, safety, and tolerability are being assessed in an open-label clinical trial (NCT06930625) recruiting participants with acromegaly or functioning GEP-NETs.
Establishing clearer diagnostic and management parameters for **RED-S** holds significant implications for athlete welfare and performance. Improved assessment tools will enable earlier identification of at-risk athle…
A terminated Phase 3 trial aimed to evaluate the safety and tolerability of weekly **TV-1106** versus daily rhGH in adults with GHD.
This ongoing trial represents a critical effort to identify a disease-modifying treatment for **Amyotrophic Lateral Sclerosis (ALS)**, a condition with profoundly limited therapeutic options. **IGF-1** holds significa…
This study offers a practical advancement for diagnosing **pediatric Growth Hormone Deficiency (GHD)**, potentially reducing the need for multiple, burdensome stimulation tests. **For clinicians, combining a low IGF-1…
Understanding the seasonal dynamics of energy availability and its impact on various physiological systems in male athletes is crucial for optimizing their health and performance. **Establishing these correlations cou…
**Standardizing autologous serum eye drop preparation is crucial for consistent clinical outcomes and patient safety.** If filtration significantly alters the concentration of therapeutic molecules, understanding thes…
If successful, this euglycemia management protocol could significantly improve outcomes for **late preterm neonates**. It would allow clinicians to leverage the proven benefits of **betamethasone** in reducing respira…
Increased Greek yogurt consumption is hypothesized to beneficially alter bone metabolism and inflammation in adolescent and young adult athletes, similar to whey protein.
Free, no account — handy when you're working with Mgf.